Task: Answer the multiple-choice question.
Question: Which drug exhibits a 9.463\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CCCCC(=O)OCCNC(=O)c1cc2ccccc2oc1=O
b.) COc1cccc(-c2csc(N3CCN(CC(=O)NNC(=O)c4ccc(Cl)cc4)CC3)n2)c1
c.) CCCCn1c(N)c(N(CC(C)C)C(=O)c2ccc(C)o2)c(=O)[nH]c1=O
d.) Clc1ccc(C2=NCCn3nc4ccccc4c32)cc1
Answer: d. Clc1ccc(C2=NCCn3nc4ccccc4c32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc(C2=NCCn3nc4ccccc4c32)cc1
Clc1ccc(C2=NCCn3nc4ccccc4c32)cc1
1-(4-chlorophenyl)-3,4-dihydropyrazino[1,2-b]indazole